Kerry Black
Corporate Officer/Principal bei RA PHARMACEUTICALS, INC.
Profil
Kerry Black is currently working as the Executive Director-Operations at Ra Pharmaceuticals, Inc. Prior to this, Ms. Black worked as a Principal at Tetraphase Pharmaceuticals, Inc. and as a Vice President-Operations at SetPoint Medical Corp.
Ms. Black holds an MBA from Babson College and has completed undergraduate and graduate degrees from the University of Maine and the University of Massachusetts, respectively.
Aktive Positionen von Kerry Black
| Unternehmen | Position | Beginn |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2010 |
Ehemalige bekannte Positionen von Kerry Black
| Unternehmen | Position | Ende |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
SetPoint Medical Corp.
 SetPoint Medical Corp. Medical/Nursing ServicesHealth Services SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA. | Geschäftsführer | - |
Ausbildung von Kerry Black
| University of Maine | Undergraduate Degree |
| University of Massachusetts | Graduate Degree |
| Babson College | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
SetPoint Medical Corp.
SetPoint Medical Corp. Medical/Nursing ServicesHealth Services SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA. | Health Services |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
